Rectal Cancer Market 2016-2024 : Technological Breakthroughs & Competitive Landscape
Stage I: Tumor is located in the first or second layer of the rectum wall but have not spread out of the rectum itself.
Stage II: Tumor spreads in the mesorectum.
Stage III: Tumor penetrates and spreads in the lymph nodes but not in order parts of the body.
Stage IV: Tumor spreads to different parts of the body, distant organs and tissues such as the lever or the lungs. It has spread outside the rectal region and stage IV is also known as metastatic rectal cancer stage.
Obtain Report Details @http://www.transparencymarketresearch.com/rectal-cancer-market.html
Rectal Cancer Market Segmentation
Based on the diagnosis, the rectal cancer market can be segmented as follows:
Digital rectal examination (DRE)
Laboratory tests, i.e., carcinoembryonic antigen (CEA) test, complete blood count etc.
Screening tests, i.e., stool DNA screening, flexible sigmoidoscopy, computed tomography (CT) colonography
Imaging tests, i.e., CT scanning of abdomen, endorectal ultrasonography, pelvic magnetic resonance imaging (MRI)
Before the treatment of a patient diagnosed with rectal cancer begins, three vital points have to be taken into consideration, i.e., the extent to which the tumor has spread, the involvement of lymph nodes and whether the tumor has spread to different parts of the body or not.
Based on the treatments involved, the rectal cancer market can be segmented as follows:
Surgery: Radical resection is the most important surgical treatment for rectal cancer. Others include transanal excision, transanal microsurgery, and endocavity radiotherapy.
Adjuvant medical therapy: Various adjuvant medical management therapies include intraoperative radiation therapy, adjuvant chemotherapy, chemoradiation therapy and radioembolization.
Antineoplastic agents (for instance, fluorouracil, leucovorin, panitumumab etc.)
Vaccines (quadrivalent papillomavirus vaccine)
Based on geographical locations, the rectal cancer market can be segmented into four major segments: North America, Europe, Asia-Pacific and Rest of the World (ROW). Out of these four regions, North America dominates the rectal cancer market followed by Europe. The major driving reasons for the growth of rectal cancer market are constantly increasing geriatric population, growing awareness about malignant effects of cancer amongst individuals, and increasing unhealthy lifestyle practices such as smoking and consumption of high fat content food. Asia-Pacific is one of the most lucrative markets for the growth of rectal cancer market and it is continuously growing at a steady rate. The advantageous factors which will contribute towards the augmentation of rectal cancer market in Asia-Pacific are high population density including the geriatric population, rapidly increasing demand for technologically advanced therapeutic treatment, and major government support for improved healthcare infrastructures such as hospitals and clinics.
Fill The Form To Gain Deeper Insights On This Market @http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14954
Various pharmaceutical companies are constantly trying to come up with novel therapeutic drugs and surgeries for the treatment of rectal cancer. Some of the top major players operating in rectal cancer therapeutics market are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG, AstraZeneca PLC, Peregrine Pharmaceuticals, Inc., AbbVie, Inc., Nanobiotix, GenVec, Inc.,and many others.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rectal Cancer Market 2016-2024 : Technological Breakthroughs & Competitive Landscape here
News-ID: 557437 • Views: 122
More Releases from Transparency Market Research
Global Emulsion Polymers Market to Expand With A Cagr Of 6.1% by the end of 2023
The report by Transparency Market Research (TMR), the global emulsion polymers market has highly fragmented and competitive landscape due to the presence of numerous players operating in the global market. Some of the key players in the market are Synthomer plc, Celanese Corporation, BASF SE, The Dow Chemical Company, Trinseo S.A., and Arkema S.A. In 2014, some of the key players such as Arkema S.A., Celanese Corporation, Dow Chemical Company,
Polyaspartic Coatings Market to Expand at a Healthy 6.6% CAGR for the 2016 - 202 …
The global polyaspartic coatings market displays a highly consolidated vendor landscape, reveals Transparency Market Research (TMR) in a new report. The presence of a small number of players makes for cut-throat competition among these players. In this scenario, to consolidate their position, top players in the polyaspartic coatings market are expanding their product portfolio, finds the report. Development of novel coatings with extended features is what top players in this
Epoxy Resins Market will develop at a CAGR of 6.9% from 2014 to 2020
A recently released report from Transparency Market Research (TMR) forecasts that the global epoxy resins market will develop at a CAGR of 6.9% from 2014 to 2020. TMR, a market intelligence firm based in the U.S., states that by 2020, the global epoxy resins market will reach a market value of US$10.55 billion from US$6.64 billion in 2013. The report, titled 'Epoxy Resins Market - Global Industry Analysis, Size, Share,
Copper Market is expected to register a growth of CAGR 4.6% during 2026
The global copper market is highly concentrated with just few prominent players in the market. However, there are several small players in the market, making it to be a highly competitive market, says Transparency Market Research (TMR) report. Get Research Report Overview @ https://www.transparencymarketresearch.com/copper-market.html An increasing number of laying of electrical poles across cities and rural areas are expected to boost the demand in the global copper market. The global copper market is
More Releases for Rectal
Colon and Rectal Cancer Drugs Market Opportunity Analysis, 2018 – 2026
Colon and rectal cancer are often grouped together, as they have many common features. Rate of colorectal cancer is increasing among the millennials in the U.S. The American Cancer Society (ACS) estimates that there will be around 97,220 new cases of colon cancer and around 43,030 new cases of rectal cancer registered in the U.S. in 2018. Moreover, owing to increasing risk of colorectal cancer, in May 2018, ACS updated
Rectal Cancer - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Rectal Cancer - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Rectal Cancer Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H1 2018, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large
Rectal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Rectal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk
Rectal Cancer-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Rectal Cancer-Pipeline Review H2 2017” this report provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or
Rectal Cancer Market : Dynamics, Segments and Supply Demand 2016-2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal
Rectal Cancer Market : Future Demand And Growth Analysis 2016-2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps